Hoboken Farms Secures $4M from Loyal Customers, Fuels Nationwide Clean-Label Sauce Expansion

Hoboken Farms, the brand celebrated for its clean-label pasta sauces, has successfully closed an unconventional funding round, securing over $4 million in fresh capital. Uniquely, the funding was led by a cohort of the brand’s most fervent loyalists—long-time farm market enthusiasts and customers—a testament to its deeply established community affinity. The investment is designed to…

Read More

Vital Lyfe Raises $24M Seed Round, Applying Aerospace Engineering to Redefine Global Water Access

Vital Lyfe, a technology company founded by former SpaceX engineering leadership, today announced it has secured $24 million in funding to accelerate the rollout of its revolutionary, portable water-making systems. The capital—comprising over $18 million in seed funding and committed debt financing—validates the company’s mission to decouple clean water access from centralized, outdated infrastructure. The…

Read More

Mobius Materials Secures $3M to Build the “Stock Market for Semiconductors

Mobius Materials, the B2B marketplace bringing liquidity and transparency to the semiconductor spot market, has successfully closed a $3 million Series Seed financing round. The investment will accelerate the development of its platform, which is designed to combat a $25 billion problem of waste and inefficiency plaguing global manufacturing, particularly amid ongoing geopolitical volatility and…

Read More

Echo Software Achieves $50M Funding Milestone in 10 Months to Lead AI-Native Cloud Security

Echo Software Ltd. (“Echo”), the emerging leader in AI-powered secure software infrastructure, has announced a rapid and highly successful funding trajectory, raising $50 million in just ten months. The latest injection is a $35 million Series A round, following a $15 million seed round announced only four months prior. This substantial backing validates Echo’s innovative…

Read More

RedotPay Secures $107 Million Series B to Propel Stablecoin Payments to Global Mainstream

RedotPay, a leading global stablecoin-based payment FinTech, has successfully closed an oversubscribed US$107 million Series B funding round. This substantial capital injection brings the company’s total funding raised in 2025 to an impressive US$194 million, reinforcing its commanding position in the digital asset application space. The funding round was led by Silicon Valley venture capital…

Read More

Nanit Raises $50 Million to Advance AI System, Unlocking Real-Time Insights into Infant Development

Nanit, the U.S.-based technology leader dedicated to early-childhood health intelligence, has announced the close of a $50 million growth capital round. This significant investment will fuel the expansion of its sophisticated AI-powered systems, moving beyond its renowned sleep tracking to provide families and clinicians with an unprecedented, holistic view of infant health and development. The…

Read More

Nanit Raises $50 Million to Advance AI System, Unlocking Real-Time Insights into Infant Development

Nanit, the U.S.-based technology leader dedicated to early-childhood health intelligence, has announced the close of a $50 million growth capital round. This significant investment will fuel the expansion of its sophisticated AI-powered systems, moving beyond its renowned sleep tracking to provide families and clinicians with an unprecedented, holistic view of infant health and development. The…

Read More

Thread Bancorp Raises $30.5 Million to Pioneer the ‘Digital Branch’ Future of Embedded Banking

Thread Bancorp, Inc. (“Thread”), the parent company of Thread Bank, today announced the successful closing of a $30.5 million funding round. The capital, comprising a $27.6 million initial raise and a $2.9 million extension, is set to significantly accelerate the company’s pioneering Embedded Banking strategy. The investment was spearheaded by Portage Ventures, a leading global…

Read More

Aeovian Pharmaceuticals Secures $55 Million to Revolutionize Treatment for Refractory Tuberous Sclerosis Complex Epilepsy

Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company focused on restoring cellular metabolic quality control, has successfully closed an oversubscribed $55 million Series B financing. This substantial investment is earmarked to propel the development of its lead candidate, AV078, a first-in-class, CNS-penetrant selective mTORC1 inhibitor, and finance the completion of its crucial Phase 2 proof-of-concept study. The…

Read More